Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KURA - Kronos Bio Seeks $175 Million IPO For AML And Solid Tumor Treatments

KURA - Kronos Bio Seeks $175 Million IPO For AML And Solid Tumor Treatments

Kura Oncology Inc.
  • Kronos Bio has filed proposed terms for a $175 million U.S. IPO.
  • The firm is advancing a pipeline of treatment candidates for acute myeloid leukemia [AML] and solid tumors.
  • KRON has shown intriguing early trial results and has a significant collaboration relationship with Gilead Sciences.
  • For long-term hold life science investors, the IPO is worth a close look.

For further details see:

Kronos Bio Seeks $175 Million IPO For AML And Solid Tumor Treatments
Stock Information
Company Name: Kura Oncology Inc.
Stock Symbol: KURA
Market: NASDAQ
Website: kuraoncology.com
Menu
KURA KURA Quote KURA Short KURA News KURA Articles KURA Message Board
Get KURA Alerts

News, Short Squeeze, Breakout and More Instantly...